What Premier Biotech does

Premier Biotech, LLC is a Minneapolis-based private drug testing diagnostics and laboratory services company founded in 2006 and backed by private equity firm Align Capital Partners since November 2022. The company manufactures point-of-collection rapid oral fluid and urine drug tests (notably OralTox, recognized as the #1 brand in rapid oral fluid testing per Current Consulting Group's 27th Annual Drug Testing Industry Survey), complementary products such as Premier Bio-Cup, Premier Bio-Dip, the Intercept i2he oral fluid collection device, and SAFE harm reduction test strips detecting fentanyl, xylazine, nitazenes, and benzodiazepines. Premier Biotech's OT-Scan digital platform automatically interprets rapid test results and produces laboratory-style reporting within minutes, while CAP-accredited forensic and SAMHSA-certified laboratories in Minneapolis and Scottsdale provide confirmatory testing for regulated programs.

The company serves employers, government agencies, healthcare providers, and background screening partners across Workplace, Government, and Clinical/Healthcare verticals, with international reach into Australia and New Zealand via the NexScreen acquisition. Premier Biotech generates revenue through one-time product sales of rapid testing kits, recurring/subscription revenue from OT-Scan and Premier Biotech Services (PBS) program administration, professional services revenue from confirmatory lab testing, and e-commerce/transaction revenue through its TransMed distribution platform. Pricing is quote-based with multi-year enterprise and government contracts; no public pricing or revenue figures are disclosed.

Since partnering with ACP, Premier Biotech has executed an active buy-and-build strategy, completing eight acquisitions including Desert Tox (June 2024, SAMHSA-certified lab), National Test Systems (November 2025, government and behavioral health), GH Solutions (April 2026, distribution), and NexScreen and TransMed (June 2026, international reach and e-commerce). The combined platform positions the company as an integrated provider spanning collection, digital interpretation, laboratory confirmation, and program management, with regulatory certifications (CAP, SAMHSA, CLIA-waived, 510(k)-cleared) forming the compliance backbone for federal, state, and clinical testing programs.

Name

Premier Biotech

Legal name

Premier Biotech, LLC.

Website

https://innovation.premierbiotech.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

51–100 employees

Short description

Premier Biotech manufactures rapid oral fluid and urine drug testing kits, the OT-Scan digital interpretation platform, and operates CAP-accredited, SAMHSA-certified laboratories. It serves employers, government agencies, healthcare providers, and background screening partners across the United States, Australia, and New Zealand.

Ownership category

akta.pro rank

Product category

Drug Testing Diagnostics

NAICS

Medical Laboratories (621511), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels) (HLAHAOAG)

akta.pro secondary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

Keywords

• Drug testing diagnostics
• Oral fluid testing
• Laboratory testing services
• Point-of-care testing
• Workplace drug screening

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Rapid Testing Products: Sales of point-of-care rapid drug testing products including OralTox oral fluid tests, Premier Bio-Cup and Premier Bio-Dip urine tests, and SAFE harm reduction test strips. Products are sold directly to employers, government agencies, and healthcare providers.
2. Laboratory Testing Services: Confirmation testing services provided through CAP-accredited forensic and SAMHSA-certified laboratories in Minneapolis and Scottsdale. Supports regulated programs requiring chain-of-custody procedures.
3. Technology and Software Services: Digital platform services including OT-Scan app for automated result interpretation and reporting, and Premier Biotech Services (PBS) for program administration, reporting, and background screening management.
4. E-commerce Distribution: Through acquired companies like TransMed, Premier operates e-commerce platforms distributing testing products and laboratory supplies to over 1,000 direct customer accounts.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

Premier Biotech manufactures and supplies rapid drug testing diagnostic devices including oral fluid and urine tests, complemented by digital interpretation tools and SAMHSA-certified/CAP-accredited laboratory confirmation services. The company serves employers, government agencies, healthcare providers, and background screening partners with an integrated testing ecosystem covering collection, interpretation, and confirmation from a single sample.

Product overview

Premier Biotech operates as an integrated drug and alcohol testing platform combining point-of-collection rapid tests with digital interpretation technology and laboratory confirmation services. The core product portfolio includes OralTox® (the #1 recognized rapid oral fluid testing brand), OT-Scan® (digital results reading and reporting app), Premier Bio-Cup and Premier Bio-Dip (rapid urine testing products), SAFE Harm Reduction Testing (adulterant detection strips), and Intercept i2he® (oral fluid collection device). These are supported by CAP-accredited forensic and SAMHSA-certified laboratory services in Minneapolis and Scottsdale, plus Premier Biotech Services (PBS) for end-to-end program management. The company has pursued an active acquisition strategy since partnering with Align Capital Partners in November 2022, acquiring Desert Tox LLC (SAMHSA-certified lab), National Test Systems (drug screening supplies), GH Solutions (point-of-care diagnostics distributor), and NexScreen/TransMed (point-of-care diagnostics and e-commerce testing supplies) to expand its footprint across workplace, government, and clinical markets.

Differentiator

Problem solved

Functional benefit

Brands

• OralTox: Point-of-collection oral fluid test, recognized as the #1 brand in rapid oral fluid drug testing.
• OT-Scan
• Premier Bio-Cup
• Premier Bio-Dip
• SAFE
• Intercept i2he
• Premier Biotech Services (PBS)

Products and services

• OralTox Rapid oral fluid drug test for use by employers, government agencies, healthcare providers, and background screening partners. Observed collection makes it nearly impossible to cheat, with results in minutes.
• OT-Scan Digital interpretation app that objectively reads OralTox test results to reduce human error and produce defensible records. Used by collectors and program administrators.
• Premier Bio-Cup Urine drug test cup for use in workplace, clinical, and government drug screening programs.
• Premier Bio-Dip Urine drug test dip card for rapid screening applications.
• SAFE Harm Reduction Testing Single-use fentanyl and xylazine test strip used for harm reduction testing.
• Intercept i2he Oral fluid collection device used for laboratory-based oral fluid drug testing programs.
• Premier Identification Kit (PIK) Identification kit used to support donor identification and chain-of-custody procedures in drug testing programs.
• Lab Services SAMHSA-certified and CAP-accredited laboratory confirmation services that produce defensible results for regulated drug testing programs.
• Premier Biotech Services (PBS) Customer service and logistics offering that simplifies test ordering and shipping for customers, with same-day shipping on most orders placed before 2 PM CT.

Quantifiable outcome

• OT-Scan automatically interprets results, delivering consistent laboratory-style reporting within minutes
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

Five partnerships are on record, tiered core.

• NexScreencoreOthers · 1 June 2026NexScreen provides point-of-care diagnostic products across the United States, Australia, and New Zealand. The acquisition expands Premier's drug and alcohol testing platform with new distribution channels and international reach.
• TransMedcoreOthers · 1 June 2026TransMed offers drug testing products and laboratory supplies to over 1,000 direct customer accounts through an e-commerce platform and international distributor network. The acquisition strengthens Premier's global footprint and online presence.
• GH SolutionscoreOthers · 1 April 2026GH Solutions is a distributor of point-of-care diagnostic testing products serving government and workplace end markets across the United States. The acquisition increases Premier's customer base and broadens its solution portfolio.
• National Test Systems (NTS)coreOthers · 1 November 2025National Test Systems is a provider of diagnostic drug screening supplies and services across the United States. The acquisition enhances Premier's customer base and strengthens its position in Government and Behavioral Health markets.
• Desert Tox LLCcoreOthers · 1 June 2024Desert Tox is a SAMHSA-certified laboratory testing services provider acquired by Premier Biotech as its first add-on since being acquired by ACP in November 2022. Desert Tox serves various markets across the U.S. and aims to expand Premier's services and customer base.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Chembio Diagnostics: Point-of-care diagnostic developer with rapid test products including drug testing panels. Comparable at the rapid test/device technology layer, though smaller and more emerging than Premier's established OralTox platform.

Direct peers

• Confirm BioSciences: Direct competitor in rapid point-of-care drug testing products including oral fluid and urine panels marketed to employers and resellers. Comparable product overlap with Premier's Premier Bio-Cup/Bio-Dip and OralTox lines at the rapid test/distribution layer.
• Drägerwerk (Dräger): Manufacturer of DrugTest 5000 and related oral fluid drug testing instruments widely used by law enforcement and workplace programs. Comparable on the rapid oral fluid instrument/consumable side of the market, particularly in criminal justice and European markets.
• OraSure Technologies: Direct peer in rapid oral fluid drug testing — maker of Intercept Oral Fluid Drug Test and the Quantisal collection device used by many employers and criminal justice programs. Closest like-for-like competitor to OralTox and Intercept i2he, with an established federal/criminal justice footprint.
• Redwood Toxicology Laboratory (acquired by ADM): Forensic and clinical toxicology lab serving workplace, legal, and clinical customers. Comparable to Premier's CAP-accredited/SAMHSA-certified lab services in Minneapolis and Scottsdale, competing on turnaround time, panel breadth, and chain-of-custody.
• Psychemedics Corporation: Specialist in workplace drug testing — though focused on hair testing rather than oral fluid. Comparable as a niche, employer-focused drug testing provider competing for similar workplace and government customers with a differentiated specimen type.

Broad incumbents

• Abbott (Rapid Diagnostics / Alere): Operates a large rapid diagnostics portfolio including point-of-care drug testing products (e.g., SoToxa oral fluid test). Comparable as a competing rapid oral fluid platform with deeper R&D and global distribution, though drug testing is one of many diagnostic categories within Abbott.
• Quest Diagnostics: Largest U.S. clinical laboratory operator with a dedicated employer services/workplace drug testing business (Quest Diagnostics Employer Solutions). Comparable because it serves the same workplace and clinical drug testing buyers through a national lab network, though its scale and breadth vastly exceed Premier Biotech.
• Thermo Fisher Scientific (Pharmaco / Clinical Diagnostics): Operates clinical and forensic toxicology testing services (including its Pharmaco and CEDIA toxicology franchises) that compete with Premier's lab confirmation services. Comparable on lab-based drug confirmation, with substantially broader life-sciences scale.
• Laboratory Corporation of America (Labcorp): National clinical laboratory with employer drug testing services and SAMHSA-certified confirmation capabilities. Comparable on the lab confirmation side of Premier's integrated workflow, though Labcorp competes at much broader scale across routine clinical diagnostics as well.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/PremierBiotech

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Premier Biotech